|
Molecular underpinnings of clinical disparity patterns in African American (AA) versus Caucasian American (CA) multiple myeloma (MM) patients. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
|
Honoraria - Cochlear (I); Oticon (I) |
Consulting or Advisory Role - Cochlear (I); Medel (I); Oticon (I) |
Research Funding - Cochlear (I); Oticon (I) |
Patents, Royalties, Other Intellectual Property - Liber (I) |
Travel, Accommodations, Expenses - Cochlear (I); Medel (I); Oticon (I) |
|
|
No Relationships to Disclose |
|
|
Honoraria - Weber Shandwick |
|
|
|
Stock and Other Ownership Interests - Tesaro (I) |
Honoraria - Celgene; Novartis |
Speakers' Bureau - Tesaro (I) |
Research Funding - Celgene |
Patents, Royalties, Other Intellectual Property - My husband receives royalties for AZD5363 or AZD5393 (not sure) an AKT inhibitor through the institute of cancer research in th eUK (I) |
Travel, Accommodations, Expenses - Celgene; Novartis; Tesaro (I) |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |